Our bodies are constantly deciding which cells should live and which should die through a process called apoptosis. This type ...

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

The new facility will enable cancer patients to take part in tailored and supervised exercise programmes, a key tool for improving their physical and emotional well-being and their tolerance of treatm ...

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...

A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, ...

Key Takeaways. Caregiver fear and availability meaningfully influence patient willingness to pursue CAR T and other immune effector therapies, contributing to persistently low uti ...

As artificial intelligence (AI) rapidly becomes part of everyday life, one question continues to dominate conversations across healthcare: Can AI replace docto ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

University of Tasmania professor Andrew Files says devils have a mutated gene that might make the carnivorous marsupial more ...

Few areas of the body face more daily stress and potential damage than the stomach, which must manage everything we swallow.

Precision oncology is reshaping cancer care in India, driven by cheaper sequencing, AI‑powered mutation discovery, and pharma ...